Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program.
about
Molecular pathology in epidemiologic studies: a primer on key considerationsSEER cancer registry biospecimen research: yesterday and tomorrowAnnual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.Prostate cancer between prognosis and adequate/proper therapy.Soy consumption and histopathologic markers in breast tissue using tissue microarrays.US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.Mammographic density and epithelial histopathologic markers.Association between oestrogens receptor expressions in breast cancer and comorbidities: a cross-sectional, population-based study.How many etiological subtypes of breast cancer: two, three, four, or more?Mammographic density and matrix metalloproteinases in breast tissue.Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival.Immunohistological analysis of ABCD3 expression in Caucasian and African American prostate tumors.Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients.Prevalence and prognostic role of triple-negative breast cancer by race: a surveillance study.DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor StatusEpidemiology of triple negative breast cancersClinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer NetworkBreast cancer characteristics and HIV among 1,092 women in Soweto, South Africa.Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the USQualitative age interactions in breast cancer studies: mind the gap.Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series.The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.Immunotherapy and gene therapy in prostate cancer treatment.Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer.
P2860
Q24598972-1146EB96-1C9C-4B20-A0FD-02F04FE6D04FQ26998744-C6FAD616-D609-4DBA-A2AD-6D1E982981C1Q27300459-15675FF3-4C53-4956-BE24-B4C2BDFF61C6Q30235459-FABE484F-AB93-47AA-A611-FECD993A637BQ30435523-9AA53A3C-FF76-4773-96DE-FAC7D65FB4A2Q30665329-C1C03BA5-FC76-4AA1-B6EE-6070866EA2E0Q33467110-66E7ABD8-EFA5-4725-8535-D76167F5B874Q33645985-6F21775B-5C3E-4DCF-9007-8382DC8EBEEDQ34106175-EFCC3558-552F-48C5-9D78-670DD8B289EBQ34268721-A4039F4A-1EF9-46AA-9AC0-E007FAAED58EQ34447257-AB0271B2-9701-4DD5-8F62-F404A9195FCDQ35087415-C75D9871-06EC-4085-9A80-F2C3096ADCFCQ35236778-78EB9419-84F0-4E01-90AE-C3B6DC59AEF5Q35694329-9FE0F26A-A683-43BA-80FC-512345D4D329Q35835922-CBF438C5-7714-4E94-A008-45728FB32A7DQ36011148-3A874B1F-94C6-48A1-AB8E-7C106440A0D2Q36386871-8C790551-DA77-491B-B4BF-9E88F17C5665Q36726996-649CFB21-AB3F-4C39-8F65-A6A28A6AFB7BQ36997747-3CA754D8-E02F-4B8F-84F0-30045D3D5609Q37390917-53A977B2-6DDA-4443-A5AA-A7C3B5280BC1Q37411636-3205037D-3227-4589-9CE6-6BE4AB810448Q37690714-9AADB9A4-7405-4502-93D8-3F776F8B0D0FQ38679395-93AF3594-BD9F-4B75-B953-57EBF5A8E69FQ41961903-9C7526BA-C527-475D-9D0C-59823EA6D6A5Q43132680-E874C6B1-EC40-4499-BE4C-93526CFDBBFA
P2860
Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Human epidermal growth factor ...... nd End Results (SEER) program.
@ast
Human epidermal growth factor ...... nd End Results (SEER) program.
@en
type
label
Human epidermal growth factor ...... nd End Results (SEER) program.
@ast
Human epidermal growth factor ...... nd End Results (SEER) program.
@en
prefLabel
Human epidermal growth factor ...... nd End Results (SEER) program.
@ast
Human epidermal growth factor ...... nd End Results (SEER) program.
@en
P2093
P2860
P50
P1476
Human epidermal growth factor ...... nd End Results (SEER) program.
@en
P2093
B Y Hernandez
M E Sherman
M P Dolled-Filhart
M Reichman
M T Goodman
P S Rosenberg
R K Matsuno
R M O'Regan
R W Cartun
P2860
P2888
P304
P356
10.1007/S10549-008-9918-3
P407
P577
2008-02-07T00:00:00Z
P5875
P6179
1011644539